ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,177.15
0.83%
Dow Jones
42,052.19
0.69%
Gold vs US Dollar
2,736.41
0.00%
Brent Oil
72.905
0.00%
Bitcoin
69,490.72
0.01%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Akero Therapeutics Inc (AKRO) Share Price

AKRO Akero Therapeutics Inc

32.33
1.50 (4.87%)
01 Nov 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Akero Therapeutics Inc NASDAQ:AKRO NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   1.50 4.87 32.33 31.90 33.26 32.95 30.92 31.885 1,253,147 23:59:30   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -151.76M -2.1858 -14.79 2.14B
 Type  Size  Price  Time  Units 
 16 358 32.33 20:02:57 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore AKRO News
02/11/202400:59EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
02/11/202400:59EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
01/11/202420:46EDGAR2Form 144 - Report of proposed sale of securities
21/10/202411:00GLOBEAkero Therapeutics to Present Data Reinforcing the Efficacy of Efruxifermin at the 75th Annual AASLD The Liver Meeting® 2024
19/10/202400:57EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
17/10/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
17/10/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
Period
Draw mode
Data Downloads for AKRO

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Akero Therapeutics Inc Articles